Surfix
PrivateLast Round
Grant
Dec 24, 2024
Total Funding Raised
$10.37M
Company Overview
Surfix operates in Healthcare & Life Sciences and is based in Wageningen. Its latest recorded funding round was a VC Round in September 2024.
Surfix is a healthtech company that develops photonic diagnostics platforms for point-of-care testing, enabling early disease detection and monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Surfix Comparables
Compare Surfix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mecwins | 81% | |
| Bialoom Ltd | 78% | |
| Genalyte | 77% |
For institutional investors. Book with your work email.
Surfix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 24, 2024 | ||||
| VC Round | Sep 4, 2024 | ||||
| Series A | May 26, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Surfix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PhotonDelta | Grant, Series A |
| PhotonVentures | VC Round |
| East Netherlands Development Agency (Oost NL) | VC Round, Series A |
| National Growth Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors grew 140% MoM, reaching 2.1K.
- Apr 17, 2026
Monthly visitors grew 142% MoM.
For institutional investors. Book with your work email.
Surfix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Surfix's valuation, stock price, and market status.
Is Surfix a public or private company?
Surfix is a private company.
What is the current stock price of Surfix?
Surfix is a private company, so its shares have no public market price. Caplight tracks Surfix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Surfix worth (valuation)?
Valuation information for Surfix is not publicly available.
Can I buy Surfix stock?
Surfix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Surfix's last funding round?
Surfix's most recent funding round was Grant on December 24, 2024.
Who are the main investors in Surfix?
Key investors in Surfix include PhotonVentures.
Will Surfix IPO soon?
No public IPO plans have been announced for Surfix.
How can I track Surfix secondary market activity?
Caplight tracks bids, offers, and trades in Surfix's shares on secondary markets.